Bouwinvest Real Estate Investors has invested $60 million in life science office buildings across the United States on behalf of its North America mandate.
Bouwinvest, Dutch institutional real estate manager, participated in Blackstone's recapitalization of BioMed Realty, bringing it closer to its goal of growing its North American portfolio to $2 billion by 2022. It is currently at $1.65 billion.
BioMed's assets are primarily located in the top-tier life science clusters in Boston, San Francisco, San Diego and Seattle.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Leslie Shaver
Les Shaver has been covering commercial and residential real estate for almost 20 years. His work has appeared in Multifamily Executive, Builder, units, Arlington Magazine in addition to GlobeSt.com and Real Estate Forum.
